SB 696
9 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
Every link on this map
The same connections as a table, with the reason each one is here.
| Schering Corporation | Lobbied on it | Schering Corporation named SB 696 in 5 lobbying reports. | 5 reports |
| California Kidney Care Alliance | Lobbied on it | California Kidney Care Alliance named SB 696 in 4 lobbying reports. | 4 reports |
| California Life Sciences | Lobbied on it | California Life Sciences named SB 696 in 4 lobbying reports. | 4 reports |
| GSK | Lobbied on it | GSK named SB 696 in 4 lobbying reports. | 4 reports |
| Lilly USA | Lobbied on it | Lilly USA named SB 696 in 4 lobbying reports. | 4 reports |
| Wyeth | Lobbied on it | Wyeth named SB 696 in 4 lobbying reports. | 4 reports |
| California Pharmacists Association | Lobbied on it | California Pharmacists Association named SB 696 in 3 lobbying reports. | 3 reports |
| Genentech, Inc., A Member of the Roche Group | Lobbied on it | Genentech, Inc., A Member of the Roche Group named SB 696 in 2 lobbying reports. | 2 reports |
| Pharmacies: prescription benefits: Medicare beneficiaries. | Source records | SB 696 has an explicit source reference to Pharmacies: prescription benefits: Medicare beneficiaries.. | None |
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…